The German Network for Personalized Medicine to enhance patient care and translational research

A L Illert^{1

2

3

4

5}, A Stenzinger^{6

7

8}, M Bitzer^{9

10}, P Horak^{7

8

11}, V I Gaidzik^{12

13}, Y Möller^{10

14}, J Beha¹⁰, Ö Öner¹⁰, F Schmitt¹⁰, S Laßmann^{3

15}, S Ossowski^{10

16

17}, C P Schaaf^{7

18}, M Hallek^{19

20}, T H Brümmendorf^{21

20}, P Albers^{22

20}, T Fehm^{23

20}, P Brossart^{24

20}, H Glimm^{25

26

27

28

29}, D Schadendorf^{30

31

32

33

34}, A Bleckmann^{35

36}, C H Brandts^{37

38}, I Esposito^{39

40}, E Mack⁴¹, C Peters^{42

43

44}, C Bokemeyer⁴⁵, S Fröhling^{7

8

11}, T Kindler^{46

47}, H Algül^{48

49}, V Heinemann^{50

51}, H Döhner⁵², R Bargou^{53

54}, V Ellenrieder⁵⁵, P Hillemanns⁵⁶, F Lordick⁵⁷, A Hochhaus⁵⁸, M W Beckmann^{59

60

61}, T Pukrop^{62

63

64}, M Trepel^{65

66

67}, L Sundmacher⁶⁸, S Wesselmann⁶⁹, G Nettekoven⁷⁰, F Kohlhuber⁷⁰, O Heinze⁷¹, J Budczies^{6

7

8}, M Werner^{3

15

43

44}, K Nikolaou⁷², A J Beer⁷³, G Tabatabai^{74

75}, W Weichert^{4

76

77

5}, U Keilholz⁷⁸, M Boerries^{3

43

79

44}, O Kohlbacher^{10

17

80

81}, J Duyster^{1

3

43

44}, R Thimme^{3

44

82}, T Seufferlein^{13

83}, P Schirmacher^{6

7

8}, N P Malek^{84

85

86}

Affiliations

¹ Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
² Department of Medicine III, Faculty of Medicine, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.
³ Center for Personalized Medicine (ZPM), Freiburg, Germany.
⁴ Center for Personalized Medicine (ZPM), Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
⁵ Bavarian Cancer Research Center (BZKF), Partner Site TU Munich, Munich, Germany.
⁶ Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
⁷ Center for Personalized Medicine (ZPM), Heidelberg, Germany.
⁸ German Cancer Consortium (DKTK), Heidelberg, Germany.
⁹ Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
¹⁰ Center for Personalized Medicine (ZPM), Tübingen, Germany.
¹¹ Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
¹² Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
¹³ Center for Personalized Medicine (ZPM), Ulm, Germany.
¹⁴ M3 Research Institute University Hospital Tübingen, Tübingen, Germany.
¹⁵ Institute for Surgical Pathology, Medical Center, University of Freiburg, Freiburg, Germany.
¹⁶ Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
¹⁷ Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen, Germany.
¹⁸ Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
¹⁹ Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
²⁰ Center for integrated Oncology (CIO-ABCD), Aachen-Bonn-Cologne-Düsseldorf, Germany.
²¹ Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
²² Department of Urology, Heinrich-Heine University, Medical Faculty, Düsseldorf, Germany.
²³ Department of Gynecology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
²⁴ Department of Oncology, Hematology, Stem Cell Transplantation, Cell- and Immunotherapies, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.
²⁵ Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), Dresden, Germany.
²⁶ German Cancer Research Center (DKFZ), Heidelberg, Germany.
²⁷ Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
²⁸ Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
²⁹ German Cancer Consortium (DKTK), Dresden, Germany.
³⁰ Department of Dermatology, University Duisburg-Essen, University Hospital Essen, Essen, Germany.
³¹ German Cancer Consortium (DKTK) Partner Site, Essen, Germany.
³² National Center for Tumor Diseases (NCT), NCT-West, Campus Essen, Essen, Germany.
³³ Westdeutsches Tumorzentrum (WTZ), Essen, Germany.
³⁴ Research Alliance Ruhr - Research Center One Health, University Duisburg-Essen, Essen, Germany.
³⁵ Department of Medicine A: Hematology, Oncology, and Pneumology, University Hospital Münster (UKM), Münster, Germany.
³⁶ West German Cancer Center, University Hospital Münster, Münster, Germany.
³⁷ University Cancer Center (UCT) Frankfurt-Marburg, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
³⁸ German Cancer Consortium (DKTK) Partner Site, Frankfurt, Germany.
³⁹ Institute of Pathology, Heinrich-Heine University and University Hospital, Düsseldorf, Germany.
⁴⁰ Center for Personalized Medicine (ZPM), Düsseldorf, Germany.
⁴¹ Department of Hematology, Oncology and Immunology, University Hospital Marburg and Philipps-University, Marburg, Germany.
⁴² Institute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.
⁴³ German Cancer Consortium (DKTK) Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Freiburg, Germany.
⁴⁴ Comprehensive Cancer Center Freiburg (CCCF), Freiburg, Germany.
⁴⁵ Department of Oncology, Hematology and BMT with section of Pneumology, University of Hamburg, Hamburg, Germany.
⁴⁶ University Cancer Center, University Medical Center Mainz, Johannes Gutenberg-University, Mainz, Germany.
⁴⁷ German Cancer Consortium (DKTK) Partner Site Mainz, Mainz, Germany.
⁴⁸ Institute for Tumor Metabolism, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
⁴⁹ Comprehensive Cancer Center Munich TUM, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
⁵⁰ Comprehensive Cancer Center Munich, Klinikum Großhadern, Ludwig Maximilian University of Munich, Munich, Germany.
⁵¹ Department of Medicine III, Klinikum Großhadern, Ludwig Maximilian University of Munich, Munich, Germany.
⁵² Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
⁵³ Comprehensive Cancer Center Mainfranken, Uniklinikum Würzburg, Würzburg, Germany.
⁵⁴ Bavarian Cancer Research Center (BZKF), Partner Site Würzburg, Würzburg, Germany.
⁵⁵ Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany.
⁵⁶ Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany.
⁵⁷ Comprehensive Cancer Center Central Germany and University Cancer Center Leipzig,, University Medicine Leipzig, Leipzig, Germany.
⁵⁸ Comprehensive Cancer Center Central Germany and Department of Hematology and Internal Oncology, Universitätsklinikum Jena, Jena, Germany.
⁵⁹ University Hospital Erlangen, Department of Obstetrics and Gynecology, Friedrich-Alexander-Universität Erlangen, Erlangen, Germany.
⁶⁰ Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nuremberg, Erlangen, Germany.
⁶¹ Bavarian Cancer Research Center (BZKF), Partner Site Erlangen, Erlangen, Germany.
⁶² Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
⁶³ Comprehensive Cancer Center Ostbayern, Regensburg, Germany.
⁶⁴ Bavarian Cancer Research Center (BZKF), Partner Site Regensburg, Regensburg, Germany.
⁶⁵ Department of Hematology and Medical Oncology, Augsburg University Hospital, Augsburg, Germany.
⁶⁶ Comprehensive Cancer Center Augsburg, CCC Alliance WERA, Augsburg, Germany.
⁶⁷ Bavarian Cancer Research Center (BZKF), Partner Site Augsburg, Augsburg, Germany.
⁶⁸ Department of Health Services Management, Ludwig-Maximilians-Universität, Munich, Germany.
⁶⁹ Deutsche Krebsgesellschaft (DKG), Berlin, Germany.
⁷⁰ Deutsche Krebshilfe, Bonn, Germany.
⁷¹ Department Medical Information Systems, University Hospital Heidelberg, Heidelberg, Germany.
⁷² Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany.
⁷³ Department of Nuclear Medicine, Ulm University Hospital, Ulm, Germany.
⁷⁴ Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, University Hospital Tübingen, Tübingen, Germany.
⁷⁵ Comprehensive Cancer Center Tübingen-Stuttgart, Stuttgart, Germany.
⁷⁶ Institute of Pathology, Technische Universität München, Munich, Germany.
⁷⁷ German Cancer Consortium (DKTK) Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Munich, Germany.
⁷⁸ Charité Comprehensive Cancer Center, Charité, Berlin, Germany.
⁷⁹ Institute of Medical Bioinformatics and Systems Medicine (IBSM), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
⁸⁰ Institute for Translational Bioinformatics, University Medical Center, Tübingen, Germany.
⁸¹ Department of Computer Science, Applied Bioinformatics, University of Tübingen, Tübingen, Germany.
⁸² Department of Medicine II, Freiburg, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
⁸³ Department of Internal Medicine I, University Hospital, University of Ulm, Ulm, Germany.
⁸⁴ Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany. nisar.malek@med.uni-tuebingen.de.
⁸⁵ Center for Personalized Medicine (ZPM), Tübingen, Germany. nisar.malek@med.uni-tuebingen.de.
⁸⁶ M3 Research Institute University Hospital Tübingen, Tübingen, Germany. nisar.malek@med.uni-tuebingen.de.

PMID: 37280276
DOI: 10.1038/s41591-023-02354-z

The German Network for Personalized Medicine to enhance patient care and translational research

A L Illert et al. Nat Med. 2023 Jun.

. 2023 Jun;29(6):1298-1301.

doi: 10.1038/s41591-023-02354-z.

Authors

Affiliations

¹ Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
² Department of Medicine III, Faculty of Medicine, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.
³ Center for Personalized Medicine (ZPM), Freiburg, Germany.
⁴ Center for Personalized Medicine (ZPM), Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
⁵ Bavarian Cancer Research Center (BZKF), Partner Site TU Munich, Munich, Germany.
⁶ Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
⁷ Center for Personalized Medicine (ZPM), Heidelberg, Germany.
⁸ German Cancer Consortium (DKTK), Heidelberg, Germany.
⁹ Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
¹⁰ Center for Personalized Medicine (ZPM), Tübingen, Germany.
¹¹ Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
¹² Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
¹³ Center for Personalized Medicine (ZPM), Ulm, Germany.
¹⁴ M3 Research Institute University Hospital Tübingen, Tübingen, Germany.
¹⁵ Institute for Surgical Pathology, Medical Center, University of Freiburg, Freiburg, Germany.
¹⁶ Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
¹⁷ Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen, Germany.
¹⁸ Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
¹⁹ Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
²⁰ Center for integrated Oncology (CIO-ABCD), Aachen-Bonn-Cologne-Düsseldorf, Germany.
²¹ Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
²² Department of Urology, Heinrich-Heine University, Medical Faculty, Düsseldorf, Germany.
²³ Department of Gynecology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
²⁴ Department of Oncology, Hematology, Stem Cell Transplantation, Cell- and Immunotherapies, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.
²⁵ Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), Dresden, Germany.
²⁶ German Cancer Research Center (DKFZ), Heidelberg, Germany.
²⁷ Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
²⁸ Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
²⁹ German Cancer Consortium (DKTK), Dresden, Germany.
³⁰ Department of Dermatology, University Duisburg-Essen, University Hospital Essen, Essen, Germany.
³¹ German Cancer Consortium (DKTK) Partner Site, Essen, Germany.
³² National Center for Tumor Diseases (NCT), NCT-West, Campus Essen, Essen, Germany.
³³ Westdeutsches Tumorzentrum (WTZ), Essen, Germany.
³⁴ Research Alliance Ruhr - Research Center One Health, University Duisburg-Essen, Essen, Germany.
³⁵ Department of Medicine A: Hematology, Oncology, and Pneumology, University Hospital Münster (UKM), Münster, Germany.
³⁶ West German Cancer Center, University Hospital Münster, Münster, Germany.
³⁷ University Cancer Center (UCT) Frankfurt-Marburg, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
³⁸ German Cancer Consortium (DKTK) Partner Site, Frankfurt, Germany.
³⁹ Institute of Pathology, Heinrich-Heine University and University Hospital, Düsseldorf, Germany.
⁴⁰ Center for Personalized Medicine (ZPM), Düsseldorf, Germany.
⁴¹ Department of Hematology, Oncology and Immunology, University Hospital Marburg and Philipps-University, Marburg, Germany.
⁴² Institute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.
⁴³ German Cancer Consortium (DKTK) Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Freiburg, Germany.
⁴⁴ Comprehensive Cancer Center Freiburg (CCCF), Freiburg, Germany.
⁴⁵ Department of Oncology, Hematology and BMT with section of Pneumology, University of Hamburg, Hamburg, Germany.
⁴⁶ University Cancer Center, University Medical Center Mainz, Johannes Gutenberg-University, Mainz, Germany.
⁴⁷ German Cancer Consortium (DKTK) Partner Site Mainz, Mainz, Germany.
⁴⁸ Institute for Tumor Metabolism, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
⁴⁹ Comprehensive Cancer Center Munich TUM, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
⁵⁰ Comprehensive Cancer Center Munich, Klinikum Großhadern, Ludwig Maximilian University of Munich, Munich, Germany.
⁵¹ Department of Medicine III, Klinikum Großhadern, Ludwig Maximilian University of Munich, Munich, Germany.
⁵² Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
⁵³ Comprehensive Cancer Center Mainfranken, Uniklinikum Würzburg, Würzburg, Germany.
⁵⁴ Bavarian Cancer Research Center (BZKF), Partner Site Würzburg, Würzburg, Germany.
⁵⁵ Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany.
⁵⁶ Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany.
⁵⁷ Comprehensive Cancer Center Central Germany and University Cancer Center Leipzig,, University Medicine Leipzig, Leipzig, Germany.
⁵⁸ Comprehensive Cancer Center Central Germany and Department of Hematology and Internal Oncology, Universitätsklinikum Jena, Jena, Germany.
⁵⁹ University Hospital Erlangen, Department of Obstetrics and Gynecology, Friedrich-Alexander-Universität Erlangen, Erlangen, Germany.
⁶⁰ Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nuremberg, Erlangen, Germany.
⁶¹ Bavarian Cancer Research Center (BZKF), Partner Site Erlangen, Erlangen, Germany.
⁶² Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
⁶³ Comprehensive Cancer Center Ostbayern, Regensburg, Germany.
⁶⁴ Bavarian Cancer Research Center (BZKF), Partner Site Regensburg, Regensburg, Germany.
⁶⁵ Department of Hematology and Medical Oncology, Augsburg University Hospital, Augsburg, Germany.
⁶⁶ Comprehensive Cancer Center Augsburg, CCC Alliance WERA, Augsburg, Germany.
⁶⁷ Bavarian Cancer Research Center (BZKF), Partner Site Augsburg, Augsburg, Germany.
⁶⁸ Department of Health Services Management, Ludwig-Maximilians-Universität, Munich, Germany.
⁶⁹ Deutsche Krebsgesellschaft (DKG), Berlin, Germany.
⁷⁰ Deutsche Krebshilfe, Bonn, Germany.
⁷¹ Department Medical Information Systems, University Hospital Heidelberg, Heidelberg, Germany.
⁷² Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany.
⁷³ Department of Nuclear Medicine, Ulm University Hospital, Ulm, Germany.
⁷⁴ Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, University Hospital Tübingen, Tübingen, Germany.
⁷⁵ Comprehensive Cancer Center Tübingen-Stuttgart, Stuttgart, Germany.
⁷⁶ Institute of Pathology, Technische Universität München, Munich, Germany.
⁷⁷ German Cancer Consortium (DKTK) Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Munich, Germany.
⁷⁸ Charité Comprehensive Cancer Center, Charité, Berlin, Germany.
⁷⁹ Institute of Medical Bioinformatics and Systems Medicine (IBSM), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
⁸⁰ Institute for Translational Bioinformatics, University Medical Center, Tübingen, Germany.
⁸¹ Department of Computer Science, Applied Bioinformatics, University of Tübingen, Tübingen, Germany.
⁸² Department of Medicine II, Freiburg, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
⁸³ Department of Internal Medicine I, University Hospital, University of Ulm, Ulm, Germany.
⁸⁴ Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany. nisar.malek@med.uni-tuebingen.de.
⁸⁵ Center for Personalized Medicine (ZPM), Tübingen, Germany. nisar.malek@med.uni-tuebingen.de.
⁸⁶ M3 Research Institute University Hospital Tübingen, Tübingen, Germany. nisar.malek@med.uni-tuebingen.de.

PMID: 37280276
DOI: 10.1038/s41591-023-02354-z

No abstract available

PubMed Disclaimer

Cited by

Advancements in Nanoporous Materials for Biomedical Imaging and Diagnostics.
Parvin N, Kumar V, Mandal TK, Joo SW. Parvin N, et al. J Funct Biomater. 2024 Aug 14;15(8):226. doi: 10.3390/jfb15080226. J Funct Biomater. 2024. PMID: 39194664 Free PMC article. Review.
Large language models-enabled digital twins for precision medicine in rare gynecological tumors.
Lammert J, Pfarr N, Kuligin L, Mathes S, Dreyer T, Modersohn L, Metzger P, Ferber D, Kather JN, Truhn D, Adams LC, Bressem KK, Lange S, Schwamborn K, Boeker M, Kiechle M, Schatz UA, Bronger H, Tschochohei M. Lammert J, et al. NPJ Digit Med. 2025 Jul 9;8(1):420. doi: 10.1038/s41746-025-01810-z. NPJ Digit Med. 2025. PMID: 40634659 Free PMC article.
Molecular diagnostics of hepatobiliary and pancreatic neoplasias.
Longerich T, Stenzinger A, Schirmacher P. Longerich T, et al. Virchows Arch. 2024 Feb;484(2):263-272. doi: 10.1007/s00428-024-03744-5. Epub 2024 Mar 1. Virchows Arch. 2024. PMID: 38429607 Free PMC article. Review.
Triple Blockade of Oncogenic RAS Signaling Using KRAS and MEK Inhibitors in Combination with Irradiation in Pancreatic Cancer.
Wang X, Breuer J, Garbe S, Giordano F, Brossart P, Feldmann G, Bisht S. Wang X, et al. Int J Mol Sci. 2024 Jun 6;25(11):6249. doi: 10.3390/ijms25116249. Int J Mol Sci. 2024. PMID: 38892436 Free PMC article.
CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer.
Romanovsky E, Menzel M, Kluck K, Beck S, Ball M, Schirmacher P, Kazdal D, Stenzinger A, Budczies J. Romanovsky E, et al. Commun Biol. 2025 Jul 29;8(1):1126. doi: 10.1038/s42003-025-08529-3. Commun Biol. 2025. PMID: 40730886 Free PMC article.

See all "Cited by" articles

References

1. Fioretos, T. et al. Nat. Med. 28, 1980–1982 (2022). - DOI - PubMed
1. Taskén, K. et al. Nat. Med. 28, 885–887 (2022). - DOI - PubMed
1. Renovanz, M. et al. Neuroncol. Adv. https://doi.org/10.1093/noajnl/vdad012 (2023). - DOI
1. Joos, S. et al. Mol. Oncol. 13, 535–542 (2019). - DOI - PubMed - PMC
1. Horak, P. et al. Cancer Discov. 11, 2780–2795 (2021). - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Grants and funding

Mildre-Scheel-Professorship/Deutsche Krebshilfe (German Cancer Aid)

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The German Network for Personalized Medicine to enhance patient care and translational research

Affiliations

The German Network for Personalized Medicine to enhance patient care and translational research

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources